A. Dąbkowska-Huć

Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

M. Olszanecka-Glinianowicz, P. Skałba, Dorota Kuglin, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

M. Olszanecka-Glinianowicz, P. Madej, J. Sikora, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Androgens in peri- and postmenopausal women

P. Skałba, A. Dąbkowska-Huć, 2006 .

Content of 5‐alpha‐reductase (type 1 and type 2) mRNA in dermal papillae from the lower abdominal region in women with hirsutism

P. Skałba, A. Samojedny, Z. Chełmicki, 2006, Clinical and experimental dermatology.

[The metabolic aspects of polycystic ovarian syndrome].

P. Skałba, A. Dąbkowska-Huć, 2005, Endokrynologia Polska.

MURCS Association with Partial Duplication of the Distal Long Chromosome 5 and Unilateral Ovarian Agenesis

A. Pyrkosz, P. Skałba, A. Dąbkowska-Huć, 2013, Case reports in genetics.

Expression of aromatase and 5-α-reductase genes in endometrial adenocarcinoma

P. Skałba, A. Samojedny, W. Każmierczak, 2006 .

Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

J. Sikora, A. Witek, P. Skałba, 2013, Endokrynologia Polska.

[The influence of anti-Mullerian hormone on folliculogenesis].

P. Skałba, A. Dąbkowska-Huć, Anna Cygal, 2008, Ginekologia polska.

[The endocrinology of the human placenta].

P. Skałba, Z. Chełmicki, A. Dąbkowska-Huć, 2003, Wiadomosci lekarskie.